The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

August 1997

Volume 37, Issue 8

Pages 667–766

  1. Issues in Clinical Pharmacology

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Intention-to-Treat Analysis in Randomized Trials: Who Gets Counted? (pages 667–672)

      Dr. Milo Gibaldi and Dr. Sean Sullivan

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04353.x

  2. Drug Development

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Selection of Doses for Phase II Clinical Trials Based on Pharmacokinetic Variability Consideration (pages 673–678)

      Dale K. Yu, Vijay O. Bhargava and Scott J. Weir

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04354.x

  3. Methodology

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Sinistrin Clearance for Determination of Glomerular Filtration Rate: A Reappraisal of Various Approaches Using a New Analytical Method (pages 679–692)

      Dr. Thierry Buclin, Dr. Antoinette Pechère-Bertschi, Dr. Romain Séchaud, Dr. Laurent A. Décosterd, Dr. Alain Munafo, Dr. Michel Burnier and Dr. Jérôme Biollaz

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04355.x

  4. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Dose-Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans (pages 693–703)

      Dr. Gary B. Kaplan, Dr. David J. Greenblatt, Dr. Bruce L. Ehrenberg, Ms. Jill E. Goddard, Monette M. Cotreau, Mr. Jerold S. Harmatz and Dr. Richard I. Shader

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04356.x

    2. Dependency of Cortisol Suppression on the Administration Time of Inhaled Corticosteroids (pages 704–710)

      Dr. Bernd Meibohm, Dr. Günther Hochhaus, Dr. Shashank Rohatagi, Dr. Helmut Möllmann, Dr. Jürgen Barth, Dr. Melanie Wagner, Dr. Michael Krieg, Dr. Ricarda Stöckmann and Dr. Hartmut Derendorf

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04357.x

    3. Pharmacokinetics and Pharmacodynamics of Midazolam After Intranasal Administration (pages 711–718)

      Dr. Aaron H. Burstein, Dr. Rosanne Modica, Dr. Michael Hatton, Dr. Alan Forrest and Dr. Fran M. Gengo

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04358.x

    4. Pharmacokinetics and Safety of the Novel Amino-3-Hydroxy-5-Methylisoxazole-4-Propionate Receptor Antagonist YM90K in Healthy Men (pages 719–727)

      Kazuo Umemura, Kazunao Kondo, Yasuhiko Ikeda, Yukari Teraya, Hisatomo Yoshida, Mariko Homma, Dr. Toshihiko Uematsu MD and Mitsuyoshi Nakashima

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04359.x

    5. Plasma Levels of Nicotine and Safety of Smokers Wearing Transdermal Delivery Systems During Multiple Simultaneous Intake of Nicotine and During Exercise (pages 728–736)

      Mr. Walid Homsy, Ms. Kerry Yan, Dr. Jean-Marie Houle, Dr. Jean-Guy Besner, Dr. Denis Gossard, Dr. Charles H. Pierce and Dr. Gilles Caillé

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04360.x

  5. Drug Interactions

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus Nonsmokers (pages 737–743)

      Poe-Hirr Hsyu, Ashish Singh, Tracie D. Giargiari, John A. Dunn, John A. Ascher and J. Andrew Johnston

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04361.x

    2. Absence of a Pharmacokinetic Interaction Between Intravenous Theophylline and Orally Administered Levofloxacin (pages 744–750)

      Dr. Lee G. Gisclon, Mr. Christopher R. Curtin, Dr. Cynthia L. Fowler, Dr. R. Rex Williams, Barry Hafkin and Dr. Jaya Natarajan

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04362.x

  6. Adverse Effects

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. Antagonism of Warfarin-Induced Hypoprothrombinemia with Use of Low-Dose Subcutaneous Vitamin K1 (pages 751–757)

      C. W. Fetrow, Timothy Overlock and Louis Leff

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04363.x

  7. Departments

    1. Top of page
    2. Issues in Clinical Pharmacology
    3. Drug Development
    4. Methodology
    5. Pharmacokinetics and Pharmacodynamics
    6. Drug Interactions
    7. Adverse Effects
    8. Departments
    1. ACCP 27th Annual Meeting Announcement (page 758)

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04364.x

    2. ACCP 26th Annual Meeting Preliminary Program (pages 759–765)

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04365.x

    3. Registration Form (page 766)

      Article first published online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04366.x

SEARCH

SEARCH BY CITATION